INNOVAX® ILT

Advantages:

• Protection against multiple diseases (MD and ILT) in single injection.
• No vaccine reaction of chicken embryo origin (CEO) ILT vaccines leads to better growth performance.
• Takes out the ILT vaccination in the growing phase, so eases the vaccination program.
• Eliminates latency, persistence, and spread caused by chickens vaccinated with live CEO conventional ILT vaccines, prevents CEO vaccine induced ILT outbreaks.
• Duration of immunity for a least 60 weeks, possible to use in combination with Nobilis® Rismavac.

Indications:

For active immunization in 18-day-old chick embryos or one-day-old chicks for the prevention of avian infectious laryngotracheitis (ILT) and Marek’s disease (MD) virus infections.

Content:

Each dose of reconstituted vaccine contains at least 2248 PFU of live virus HVT (Herpesvirus of Turkey) strain HVT/ILT-138 in the cell-associated form.

Dosing and Administration:

The vaccine is given by injection. Use Nobilis® Diluent CA for reconstitution alone or in combination. For subcutaneous injection, 0.2 ml was given to each chicken in the neck at the age of one day. For in-ovo route, vaccination on chicken embryos aged 18 days with a dose of 0.05 ml.

Storage:

Ampoules – store in a filled liquid nitrogen container.

Diluent – store at room temperature (15°C – 25°C).

Container – store liquid nitrogen container securely in upright position in a clean, dry and well-ventilated room separated from the hatching/chicken room in the hatchery.